The interaction between HIV and malaria in Africa

Current Infectious Disease Reports

Volumn 9, Issue 1, 2007, Pages 47-54

  Laufer, Miriam K ^b   Plowe, Christopher V ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; FOLIC ACID ANTAGONIST; INSECTICIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AFRICA; AIDS RELATED COMPLEX; ANTIGEN ANTIBODY REACTION; ANTIMALARIAL ACTIVITY; BACTERIAL INFECTION; BED NET; CD4+ T LYMPHOCYTE; CHILDHOOD DISEASE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENVIRONMENTAL EXPOSURE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE INFECTION; LYMPHOCYTE COUNT; MALARIA; MORTALITY; NONHUMAN; PARASITEMIA; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PREGNANT WOMAN; PRENATAL EXPOSURE; PROTECTIVE CLOTHING; REVIEW; RISK ASSESSMENT; RISK FACTOR; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 33846985615     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-007-0022-3     Document Type: Review

References (48)

1. Whitworth JA, Hewitt KA: Effect of malaria on HIV-1 progression and transmission. Lancet 2005, 365:196-197.
2. Corbett EL, Watt CJ, Walker N, et al.: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163:1009-1021.
3. Hay SI, Guerra CA, Tatem AJ, et al.: The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004, 4:327-336.
4. Butcher GA: T-cell depletion and immunity to malaria in HIV-infections. Parasitology 2005, 130:141-150.
5. Reyburn H, Mbatia R, Drakeley C, et al.: Association of transmission intensity and age with clinical manifestations and case fatality of severe plasmodium falciparum malaria. JAMA 2005, 293:1461-1470.
6. Struik SS, Riley EM: Does malaria suffer from lack of memory? Immunol Rev 2004, 201:268-290.
7. Fried M, Nosten F, Brockman A, et al.: Maternal antibodies block malaria. Nature 1998, 395:851-852.
8. Steketee RW, Wirima JJ, Slutsker L, et al.: Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi Am J Trop Med Hyg 1996, 55:17-23.
9. Hoffman IF, Jere CS, Taylor TE, et al.: The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999, 13:487-494.
10. Kublin JG, Patnaik P, Jere CS, et al.: Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005, 365:233-240.
11. Bush CE, Donovan RM, Markowitz NP, et al.: A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:23-26.
12. Donovan RM, Bush CE, Markowitz NP, et al.: Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996, 174:401-403.
13. Goletti D, Weissman D, Jackson RW, et al.: Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996, 157:1271-1278.
14. Francesconi P, Fabiani M, Dente MG, et al.: HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS 2001, 15:2445-2450.
15. Colebunders R, Bahwe Y, Nekwei W, et al.: Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J Infect 1990, 21:167-173.
16. Patnaik P, Jere CS, Miller WC, et al.: Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis 2005, 192:984-991.
17. Sulo J, Chimpeni P, Hatcher J, et al.: Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet 2002, 360:1136-1143.
18. Laufer MK, van Oosterhout JJ, Thesing PC, et al.: Impact of HIV-associated immunosuppression on malaria infection and disease in malawi. J Infect Dis 2006, 193:872-878.
19. Smith T, Schellenberg JA, Hayes R: Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 1994, 13:2345-2358.
20. French N, Nakiyingi J, Lugada E, et al.: Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001, 15:899-906.
21. Grimwade K, French N, Mbatha DD, et al.: HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 2004, 18:547-554.
22. Cohen C, Karstaedt A, Frean J, et al.: Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis 2005, 41:1631-1637.
23. Laufer MK, van Oosterhout JJ, Perez MA, et al.: Observational cohort study of HIV-infected African children. Pediatr Infect Dis J 2006, 25:623-627.
24. Greenberg AE, Nsa W, Ryder RW, et al.: Plasmodium-falciparum malaria and perinatally acquired human immunodeficiency virus type-1 infection in Kinshasa, Zaire - a prospective, longitudinal cohort study of 587 children. N Engl J Med 1991, 325:105-109.
25. Kalyesubula I, Musoke-Mudido P, Marum L, et al.: Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J 1997, 16:876-881.
26. Taha TE, Canner JK, Dallabetta GA, et al.: Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi. Trans R Soc Trop Med Hyg 1994, 88:164-165.
27. Hviid L, Staalsoe T: Malaria immunity in infants: a special case of a general phenomenon? Trends Parasitol 2004, 20:66-72.
28. Grimwade K, French N, Mbatha DD, et al.: Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J 2003, 22:1057-1063.
29. Yeung S, Wilkinson D, Escort S, et al.: Paediatric HIV infection in a rural South African district hospital. J Trop Pediatr 2000, 46:107-110.
30. Coleman RL, Wilkinson D: Increasing HIV prevalence in a rural district of South Africa from 1992 through 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:50-53.
31. Otieno RO, Ouma C, Ong'echa JM, et al.: Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006, 20:275-280.
32. Ter Kuile FO, Parise ME, Verhoeff FH, et al.: The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004, 71:41-54.
33. van Eijk AM, Ayisi JG, Ter Kuile FO, et al.: HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 2003, 17:595-603.
34. Mount AM, Mwapasa V, Elliott SR, et al.: Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004, 363:1860-1867.
35. van Oosterhout JJ, Laufer MK, Graham SM, et al.: A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr 2005, 39:626-631.
36. Djimde AA, Doumbo OK, Traore O, et al.: Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 2003, 69:558-563.
37. Birku Y, Makonnen E, Bjorkman A: Comparison of rectal artemisinin with intravenous quinine in the treatment of severe malaria in Ethiopia. East Afr Med J 1999, 76:154-159.
38. Kamya MR, Gasasira AF, Yeka A, et al.: Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 2006, 193:9-15.
39. Mellors JW, Rinaldo CR Jr, Gupta P, et al.: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
40. Quigley MA, Hewitt K, Mayanja B, et al.: The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults. Trop Med Int Health 2005, 10:894-900.
41. Mermin J, Lule JR, Ekwaru JP: Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 2006, 41:129-130.
42. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al.: The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 2003, 17:2539-2541.
43. Gallagher M, Malhotra I, Mungai PL, et al.: The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005, 19:1849-1855.
44. Inion I, Mwanyumba F, Gaillard P, et al.: Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003, 188:1675-1678.
45. Ayisi JG, van Eijk AM, Newman RD, et al.: Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004, 10:643-652.
46. Korenromp EL, Williams BG, de Vlas SJ, et al.: Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis 2005, 11:1410-1419.
47. Mermin J, Ekwaru JP, Liechty CA, et al.: Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006, 367:1256-1261.
48. Whitworth J, Morgan D, Quigley M, et al.: Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000, 356:1051-1056.